Application Information

This drug has been submitted to the FDA under the reference 206843/001.

Names and composition

"DAKLINZA" is the commercial name of a drug composed of DACLATASVIR DIHYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
206843/001 DAKLINZA DACLATASVIR DIHYDROCHLORIDE TABLET/ORAL EQ 30MG BASE
206843/002 DAKLINZA DACLATASVIR DIHYDROCHLORIDE TABLET/ORAL EQ 60MG BASE
206843/003 DAKLINZA DACLATASVIR DIHYDROCHLORIDE TABLET/ORAL EQ 90MG BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
206843/001 DAKLINZA DACLATASVIR DIHYDROCHLORIDE TABLET/ORAL EQ 30MG BASE
206843/002 DAKLINZA DACLATASVIR DIHYDROCHLORIDE TABLET/ORAL EQ 60MG BASE
206843/003 DAKLINZA DACLATASVIR DIHYDROCHLORIDE TABLET/ORAL EQ 90MG BASE

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved